Department of Urology, Queen's University, Kingston General Hospital, Kingston, Ontario, Canada.
J Urol. 2010 Oct;184(4):1358-63. doi: 10.1016/j.juro.2010.06.005. Epub 2010 Aug 17.
We characterized and compared the impact of clinical phenotypic associations between interstitial cystitis/painful bladder syndrome and controls in relation to potentially related conditions, particularly irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
Female patients with interstitial cystitis/painful bladder syndrome and controls with no interstitial cystitis/painful bladder syndrome completed a biopsychosocial phenotyping questionnaire battery which included demographics/history form, self-reported history of associated conditions, and 10 validated questionnaires focused on symptoms, suffering/coping and behavioral/social factors.
Questionnaires were completed by 205 patients with interstitial cystitis/painful bladder syndrome and 117 controls matched for age. Prevalence of self-reported associated condition diagnosis in interstitial cystitis/painful bladder syndrome vs controls was irritable bowel syndrome 38.6% vs 5.2%, fibromyalgia 17.7% vs 2.6% and chronic fatigue syndrome 9.5% vs 1.7% (all p <0.001). In the interstitial cystitis/painful bladder syndrome cohort 50.3% reported no other associated condition, 24.4% had interstitial cystitis/painful bladder syndrome + irritable bowel syndrome only, 2.5% had interstitial cystitis/painful bladder syndrome + fibromyalgia only, 1.5% had interstitial cystitis/painful bladder syndrome + chronic fatigue syndrome only, while 20.2% had multiple associated conditions. As the number of associated conditions increased (ie localized, regional, systemic), pain, stress, depression and sleep disturbance increased while social support, sexual functioning and quality of life deteriorated. Anxiety and catastrophizing remained increased in all groups. Symptom duration was associated with this apparent phenotypic progression.
Irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome are more prevalent in patients with interstitial cystitis/painful bladder syndrome than in asymptomatic control subjects, and result in significant impact. There are at least 3 distinct clinical phenotypes based on identification of overlapping syndrome patterns. A suggestion that remains to be proven with longitudinal studies is that there may be progression over time from an organ centric to a regional and finally to a systemic pain syndrome with progression of symptom severity, and deterioration of cognitive and psychosocial parameters.
我们对间质性膀胱炎/膀胱疼痛综合征(IC/BPS)患者与对照者之间的临床表型关联进行了特征描述和比较,这些关联与潜在相关疾病有关,特别是肠易激综合征(IBS)、纤维肌痛症(fibromyalgia)和慢性疲劳综合征(chronic fatigue syndrome,CFS)。
患有 IC/BPS 的女性患者和无 IC/BPS 的对照者完成了一份生物心理社会表型问卷,其中包括人口统计学/病史表、自述相关疾病史,以及 10 项针对症状、痛苦/应对和行为/社会因素的经过验证的问卷。
205 名 IC/BPS 患者和 117 名年龄匹配的对照者完成了问卷。在 IC/BPS 患者与对照者中,自我报告的相关疾病诊断的患病率分别为:IBS 38.6%对 5.2%、纤维肌痛症 17.7%对 2.6%和 CFS 9.5%对 1.7%(均<0.001)。在 IC/BPS 患者队列中,50.3%的患者报告没有其他相关疾病,24.4%的患者仅患有 IC/BPS+IBS,2.5%的患者仅患有 IC/BPS+纤维肌痛症,1.5%的患者仅患有 IC/BPS+CFS,而 20.2%的患者患有多种相关疾病。随着相关疾病数量的增加(即局部、区域、全身),疼痛、压力、抑郁和睡眠障碍增加,而社会支持、性功能和生活质量恶化。焦虑和灾难化思维在所有组中仍然增加。症状持续时间与这种明显的表型进展相关。
与无症状对照者相比,IBS、纤维肌痛症和 CFS 在 IC/BPS 患者中更为常见,并且对患者产生了显著影响。根据重叠综合征模式的识别,至少存在 3 种不同的临床表型。需要通过纵向研究来证明的一个观点是,随着时间的推移,可能会从器官中心向区域性、最后向系统性疼痛综合征发展,同时症状严重程度加重,认知和社会心理参数恶化。